Reckitt Benckiser Group plc

The current price of RBGLY is $15.20 — it has decreased by 0.91% since the previous close. Data as of Nov 5, 2026.

RBGLY is up 4.32% over the past week, up 14.29% over the past month and down 26.00% over the past year. The price is above its 200-day moving average of $14.13.

Of the 4 analysts covering Reckitt Benckiser Group plc, 1 rates it a strong buy, 1 rates it a buy and 2 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.

Reckitt Benckiser Group plc has a market capitalization of $48.13B. The company belongs to the Consumer Defensive sector. Compare it with other companies in the stock screener.

In its most recent quarterly report, Reckitt Benckiser Group plc posted earnings of $0.2687 per share against an estimate of $0.3807, missing expectations by 29.42%. Upcoming reports are listed in the earnings calendar.

Reckitt Benckiser Group plc reported revenue of $8.52B in its most recent quarter, which has decreased by 9.89% compared with the same quarter a year earlier. Analysts had expected $8.25B.

Yes. Reckitt Benckiser Group plc pays dividends quarterly. The latest payment of $0.2359 per share has a payment date of Sep 28, 2026, which corresponds to a dividend yield of 8.46%.

Companies most comparable to Reckitt Benckiser Group plc include The Procter & Gamble Company, L'Oréal S.A., Unilever PLC, Colgate-Palmolive Company and The Estée Lauder Companies Inc.

In the latest trading session RBGLY moved between $15.19 and $15.42, a range of 1.51% of its current price.

Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Reckitt Benckiser Group plc shows a buy rating today. Technical ratings are indicators, not investment advice.

Over the past 52 weeks RBGLY has traded between $12.02 and $17.80. The current price is 14.61% below its 52-week high.